Roche gets US FDA approval for Tecentriq combo to treat advanced melanoma EP News Bureau Jul 31, 2020 The approval is based on results from the Phase III IMspire150 study, in which the addition of Tecentriq to Cotellic and Zelboraf…
Roche’s Tecentriq cocktail scores trial success in melanoma Reuters Dec 13, 2019 The study met its primary aim of showing progression-free survival in patients with previously untreated BRAF V600…
Roche says Tecentriq prevents disease worsening or death in patients with advanced bladder cancer Reuters Aug 6, 2019 Roche is evaluating treatment in combination with other medicines for early, advanced forms of disease
